ArticleEndocrine connections2025

A real-world retrospective analysis to evaluate the efficacy and safety of surufatinib in the treatment of advanced neuroendocrine neoplasms in China.

Shutong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.